DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Stifel Nicolaus Maintains Hold on Aimmune Therapeutics, Lowers Price Target to $32

Stifel Nicolaus maintains Aimmune Therapeutics (NASDAQ:AIMT) with a Hold and lowers the price target from $34 to $32.

Benzinga · 03/02/2020 13:16

Stifel Nicolaus maintains Aimmune Therapeutics (NASDAQ:AIMT) with a Hold and lowers the price target from $34 to $32.